AXIOMER
Live / Registered — Cancelled — Section 71 (as of 12 Jan 2024)
What this means for you
Registered since 27 Jun 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79192823
- Registration number
- 5229979
- Mark type
- Word mark
- Filed
- 23 Mar 2016
- Published for opposition
- 10 Jan 2017
- Registered
- 27 Jun 2017
- Attorney of record
- Krista Weber Powell
Goods and services
- Class 001 — Chemicals: [ Chemical compounds for scientific or research purposes ]
- Class 005 — Pharmaceuticals: [ Pharmaceutical preparations for the treatment, diagnosis and prevention of genetic diseases and disorders; ] pharmaceutical preparations for the treatment of genetic diseases based on oligonucleotides, [ oligoribonucleotides, aptamers, nucleic acid molecules, dna, ] * for use in * rna [, polynucleotides, ribozymes, mirnas, snornas, mrnas or sirnas ]
- Class 042 — Scientific and technological services: [ Laboratory research services relating to pharmaceuticals; medical research; pharmaceutical research and development; laboratory research and analysis in the field of medicines; services of biotechnological, chemical and pharmacological laboratories, including scientific and technological research, in relation to the production of chemicals and biotechnological products for use in the preparation of pharmaceuticals; development of pharmaceutical preparations and medicines; development of technologies for the production of pharmaceutical semi finished and/or finished preparations; academic research, medical and biochemical research and development services; chemistry, laboratory technicians' and engineering services; research and development in the field of biotechnology; research into and development and testing of pharmaceutical and biochemical semi- finished products, in particular for use in medicines, research into and development and testing of medicines; development of test systems for pharmaceutical, medical and sanitizing preparations; services development and identification of and research into new drug targets ]
Owner
Prosecution history
- 07 Oct 2024 — TOTAL INVALIDATION PROCESSED BY THE IB
- 14 Sept 2024 — TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
- 14 Sept 2024 — INVALIDATION PROCESSED
- 13 Sept 2024 — TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
- 12 Jan 2024 — CANCELLED SECTION 71
- 27 Jun 2022 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 12 Apr 2018 — INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
- 08 Apr 2018 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
- 28 Oct 2017 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 28 Sept 2017 — FINAL DISPOSITION NOTICE SENT TO IB
- 28 Sept 2017 — FINAL DISPOSITION PROCESSED
- 27 Sept 2017 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 08 Aug 2017 — LIMITATION FROM THE IB EXAMINED AND ENTERED
- 08 Aug 2017 — CORRECTION UNDER SECTION 7 - PROCESSED
- 08 Aug 2017 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL